Sign In
Buy PGNY
$26.28
+0.200 (+0.767%)
At Close: Jun 22, 2026
Bronstein, Gewirtz & Grossman, LLC Encourages Progyny, Inc. (PGNY) Investors to Inquire about Securities Investigation
10:00am, Sunday, 22'nd Sep 2024
NEW YORK CITY, NY / ACCESSWIRE / September 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Progyny, Inc. ("Progyny" or "the Company") (NASDAQ
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Progyny, Inc. (PGNY)
04:30pm, Friday, 20'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Progyny, Inc. ("Progyny, Inc.") (NASDAQ:PGNY) concerning possible violati
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Progyny, Inc. (“Progyny” or “th
The Law Offices of Frank R. Cruz Announces Investigation of Progyny, Inc. (PGNY) on Behalf of Investors
02:47pm, Friday, 20'th Sep 2024
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY) on behalf of investors concerning the Com
NEW YORK, NY / ACCESSWIRE / September 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Progyny, Inc. ("Progyny, Inc.") (NASDAQ:PGNY) concerning possible violati
Lost Money on Progyny, Inc. (PGNY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
12:45pm, Friday, 20'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Progyny, Inc. ("Progyny, Inc.") (NASDAQ:PGNY) concerning possible violati
NEW YORK CITY, NY / ACCESSWIRE / September 20, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Progyny, Inc. ("Progyny" or "the Company") (NASDAQ
Progyny (PGNY) Crashes After Losing Significant Client - Hagens Berman
02:46pm, Thursday, 19'th Sep 2024
SAN FRANCISCO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Progyny, Inc. (NASDAQ: PGNY) investors who suffered substantial losses to submit your losses now. The firm also encourages persons
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progyny, Inc. - PGNY
02:45pm, Thursday, 19'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ:PGNY). Such investors are advised to
NEW YORK CITY, NY / ACCESSWIRE / September 19, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Progyny, Inc. ("Progyny" or "the Company") (NASDAQ
Fertility-benefits provider Progyny's stock on track for biggest-ever decline after losing ‘significant' client
01:38pm, Thursday, 19'th Sep 2024
Progyny Inc.'s stock tumbled 31% Thursday, to put it on track for its biggest-ever one-day decline, after the provider of fertility-care benefits for employers said a “significant” client had term
Why Progyny Stock Is Crashing Today
11:37am, Thursday, 19'th Sep 2024
Progyny revealed that it's losing a major client. While the client name wasn't disclosed, it accounted for 12% of Progyny's total revenue in the first half of 2024.
Top 3 Health Care Stocks That Are Set To Fly This Quarter
07:57am, Friday, 16'th Aug 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Progyny: Downgrading As Uncertainties Increase
01:32pm, Thursday, 15'th Aug 2024
Progyny lowered full-year revenue guidance after seeing an unexpected drop in user utilization rates. The Harris-Walz ticket has put fertility benefits center stage in the upcoming presidential electi
Progyny EPS Outperforms, Revenue Dips in Q2
09:13am, Thursday, 08'th Aug 2024
Revenue of $304.1 million met management's expectations. Adjusted EPS of $0.43 outperformed management's guidance.
